Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 3Phase 1/2 2Phase 2/3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Non-Small-Cell Lung 255Breast Neoplasms 171Neoplasms 166Colorectal Neoplasms 152Neoplasm Metastasis 125Prostatic Neoplasms 118Recurrence 117Leukemia, Myeloid, Acute 117Melanoma 116Pancreatic Neoplasms 114Ovarian Neoplasms 109Multiple Myeloma 105Lung Neoplasms 94Stomach Neoplasms 92Triple Negative Breast Neoplasms 86Squamous Cell Carcinoma of Head and Neck 86Lymphoma 77Glioblastoma 77Lymphoma, Non-Hodgkin 76Lymphoma, Large B-Cell, Diffuse 65Carcinoma, Renal Cell 64Precursor Cell Lymphoblastic Leukemia-Lymphoma 63Carcinoma, Hepatocellular 58Endometrial Neoplasms 56Advanced Solid Tumor 56Small Cell Lung Carcinoma 55Uterine Cervical Neoplasms 53Sarcoma 53Myelodysplastic Syndromes 51Leukemia 50

Interventions

Saline Solution 1Cell- and Tissue-Based Therapy 1Ambulatory Care Facilities 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Erectile Dysfunction × 1 year × Clear all
NCT07048314 2026-03-19

Stem Cells for Erectile Dysfunction Post RALP

The Methodist Hospital Research Institute

Phase 1/2 Not yet recruiting
40 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT01089387 2025-12-04

INSTIN

Institut National de la Santé Et de la Recherche Médicale, France

Phase 1/2 Completed
18 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡